| Part Of Washington Journal 10/18/11
Washington Journal
Report Video IssueWashington Journal
Drug Approval Process, Part 1
2011-10-18T09:19:57-04:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvMzg3XC8zMDIxNDUtMDUtbS5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented several drugs including Sutent for kidney cancer and Zelboraf for melanoma. He responded to telephone calls and electronic communications.
Mr. Hirth participated from San Francisco.
Due to a signal loss, the program ends abruptly, and approximately eight minutes of the program were lost. Part two can viewed using program identification number 302145-101.
Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented sever…
read more
Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented several drugs including Sutent for kidney cancer and Zelboraf for melanoma. He responded to telephone calls and electronic communications.
Mr. Hirth participated from San Francisco.
Due to a signal loss, the program ends abruptly, and approximately eight minutes of the program were lost. Part two can viewed using program identification number 302145-101. close
Mr. Hirth participated from San Francisco.
Due to a signal loss, the program ends abruptly, and approximately eight minutes of the program were lost. Part two can viewed using program identification number 302145-101.
Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented sever… read more
Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented several drugs including Sutent for kidney cancer and Zelboraf for melanoma. He responded to telephone calls and electronic communications.
Mr. Hirth participated from San Francisco.
Due to a signal loss, the program ends abruptly, and approximately eight minutes of the program were lost. Part two can viewed using program identification number 302145-101. close
People in this video
Hosting Organization
Series
More Videos From
Washington Journal 10/18/11
- Richard Trumka on Occupy Wall Street Protests
- Drug Approval Process, Part 1
- Drug Approval Process, Part 2
Purchase a Download
Drug Approval Process, Part 1
-
MP4 video - Standard
- Price:
- $4.99
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Drug Approval Process, Part 2
Peter Hirth talked about he pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest…
-
Allan Coukell on FDA Reform Act of 2012
Allan Coukell, deputy director of the Medical Safety Portfolio of the Pew Health Group, talked about the drug safety. Ea…
-
Open Phones
Viewers talked about their views on governments controlling Internet content. The discussion stemmed from violence direc…
-
Open Phones
Telephone lines were open for viewer responses to the question, “Have your medication costs increased?”